A new TB vaccine for adolescents and adults, developed by IIT and ILS Bhubaneswar, is set for commercialisation.

India is moving closer to commercialising a new tuberculosis vaccine — the HSP Subunit Vaccine in Adjuvant (DDA). Developed ...

Wealthier consumptive patients had long been directed to salubrious locations such as seaside resorts or spa towns to escape ...

The vaccine triggers strong immune responses against Mycobacterium tuberculosis and is licensed for commercial development to ...

“To address this critical unmet need, a next-generation HSP Subunit Vaccine has been developed through collaborative research ...

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...

The United States endobronchial ultrasound (EBUS) biopsy market is projected to grow from USD 246.82 billion in 2024 to USD ...

The HSP Subunit Vaccine candidate, jointly developed by the Institute of Life Sciences (ILS), Bhubaneswar, and the Indian Institute of Technology (IIT) Bhubaneswar, marks a significant advancement in ...

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS), along with the ...

Three Indian research institutes have signed an agreement with TechInvention Lifecare Limited for the technology transfer and future commercialisation of a novel TB vaccine candidate<br />The Indian ...

The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...

The lives and respiratory health of Palestinians are at risk. In the Gaza Strip, the average life expectancy decreased by 34·9 years1 and over 59 587 Palestinians (including 17 921 children) were ...